…the discovery and development of novel mRNA-based cancer vaccines by leveraging Moderna’s knowledge of mRNA science and customised information from Immatics’ wealth of tumour and normal tissue data, which is…
…for FGFR alterations in all patients with metastatic UC.” FDA approval In April 2019, erdafitinib received accelerated approval from the US Food and Drug Administration (FDA) as a targeted therapy…
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn…
…solutions that enhance preclinical R&D productivity. Our growing portfolio equips researchers with robust capabilities to illuminate scientific discoveries and can expedite the journey from discovery to cure. “With these advanced…
…in unlocking new insight and accelerating drug discovery with AI. What you will learn: What are the benefits of AI in drug discovery? How can this technology improve time to…
…of drug and gene therapies’ will take place on 28 September 4PM BST, 5PM CEST, EDT 11AM, PDT 8AM. Register for free here. Speakers: Chris Kirton, Chief Executive Officer, DefiniGEN…
…and the second, a therapeutic drug, to act on those cells. Both the diagnostic agent and therapeutic drug contain Ariceum’s proprietary peptide satoreotide, a first-in-class and best-in-class antagonist of the…
…by the UK and EU to admit the UK back into Horizon Europe, the largest collaborative research programme in the world. You can listen below, or find The Drug Discovery…
…Development have agreed a target discovery collaboration to evaluate novel biological targets for the treatment of haematological cancers. Optibrium acquires BioPharmics AI drug discovery company Optibrium has acquired 3D drug…
…Committee for Medicinal Products for Human Use (CHMP) recommended the drug for approval in the EU in August. An application has also been submitted to the US Food and Drug…
…immune response, in cases of Alzheimer’s and vascular dementia. This finding will open new avenues in drug discovery for Alzheimer’s disease as potential new treatments could focus on reducing microglial…
This is the latest episode of the free DDW narrated podcast, “How is mass spectrometry advancing drug discovery?”, which covers two articles written for Volume 23, Issue 3 – Summer…
…UK innovation and research depends on international collaborations which are crucial for driving advancements in all areas of science, including the discovery and early development of new medicines and vaccines.”…
